{{Rsnum
|rsid=2455069
|Gene=CD33
|Chromosome=19
|position=51225385
|Orientation=plus
|GMAF=0.3489
|Gene_s=CD33
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 30.1 | 46.0 | 23.9
| HCB | 83.9 | 15.3 | 0.7
| JPT | 90.3 | 9.7 | 0.0
| YRI | 17.7 | 53.1 | 29.3
| ASW | 28.1 | 49.1 | 22.8
| CHB | 83.9 | 15.3 | 0.7
| CHD | 81.7 | 18.3 | 0.0
| GIH | 54.5 | 38.6 | 6.9
| LWK | 30.0 | 50.0 | 20.0
| MEX | 61.4 | 35.1 | 3.5
| MKK | 27.0 | 59.9 | 13.2
| TSI | 25.5 | 53.9 | 20.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=23444229
|Title=Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin-Containing Chemotherapy
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}